Edmund K. Moon

7.0k citations

43 papers · 4.9k indexed · 4 hit papers · h-index 26

Oncology top 0.5%
- CAR-T cell therapy research 24
- Cancer Immunotherapy and Biomarkers 9
Immunology top 1%
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 4
Genetics top 1%
- Virus-based gene therapy research 9
Biotechnology top 2%
- Cancer Research and Treatments 6
Biomedical Engineering top 2%
Pulmonary and Respiratory Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4

Co-authors: Steven Μ. Albelda Marina C. Martinez Kheng Newick Shaun O’Brien Carl H. June Veena Kapoor Albert Lo Liang‐Chuan S. Wang
Cited by: Oncology Immunology Genetics
Journals: OncoImmunology (5 papers)Molecular Therapy (4 papers)Cancer Research (4 papers)
Partner nations: United States Slovakia Belgium

In The Last Decade

Edmund K. Moon

43 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2019 Frontiers in Immunology
2016 Annual Review of Medicine
2016 Cancer Research
2011 Clinical Cancer Research

Peers

Countries citing papers authored by Edmund K. Moon

Since Specialization

Citations

This map shows the geographic impact of Edmund K. Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund K. Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund K. Moon more than expected).

Fields of papers citing papers by Edmund K. Moon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund K. Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund K. Moon. The network helps show where Edmund K. Moon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edmund K. Moon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edmund K. Moon Line = papers co-authored together Edmund K. Moon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	OA16.01 Plasma NGS At Time of Diagnostic Tissue Biopsy – Impact on Time to Treatment: Results From a Pilot Prospective Study Journal of Thoracic Oncology ·James Thompson,Charu Aggarwal,J. Wong,Sasweta Pattnaik,بسام بن صالح الحربي,David M. DiBardino,3 . R Walker 1,Tayebeh Anajafi Marzijarani,Anthony R. Lanfranco,Edmund K. Moon,Andrew R. Haas,Anil Vachani,Erica L. Carpenter	2021	2
2	Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo Molecular Therapy ·Sarah A. Richman,Liang-Chuan Wang,Edmund K. Moon,Uday R. Khire,Steven Μ. Albelda,Michael C. Milone	2020	69
3	Efficacy and safety of airway stenting to treat anastomotic complications after lung transplant: a cohort study Journal of Thoracic Disease ·C. Kevin,Mingyang Li,Andrew R. Haas,Anthony R. Lanfranco,Edmund K. Moon,David M. DiBardino	2020	9
4	Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes OncoImmunology ·Astero Klampatsa,Shaun O’Brien,Jeffrey C. Thompson,Abhishek Rao,Jason Stadanlick,Marina C. Martinez,Maria Liousia,Edward Cantu,Keith A. Cengel,Edmund K. Moon,Sunil Singhal,Evgeniy Eruslanov,Steven Μ. Albelda	2019	34
5	Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer Cancer Immunology Research ·Shaun O’Brien,Astero Klampatsa,Jeffrey C. Thompson,Marina C. Martinez,Wei‐Ting Hwang,Bartholomew Moore,Oziel Saturnino,Soyeon Kim,Edward Cantu,Leslie A. Litzky,Sunil Singhal,Evgeniy Eruslanov,Edmund K. Moon,Steven Μ. Albelda	2019	67
6	A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumorsbreakdown → Cancer Research ·Xiaojun Liu,Raghuveer Ranganathan,Shuguang Jiang,Chongyun Fang,Jing Sun,Soyeon Kim,Kheng Newick,Albert Lo,Carl H. June,Yangbing Zhao,Edmund K. Moon	2016	420
7	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization Cancer Immunology Research ·Kheng Newick,Shaun O’Brien,Jing Sun,Veena Kapoor,何南熹,Albert Lo,Ellen Puré,Edmund K. Moon,Steven Μ. Albelda	2016	160
8	Chimeric antigen receptor T-cell therapy for solid tumors Molecular Therapy — Oncolytics ·Kheng Newick,Edmund K. Moon,Steven Μ. Albelda	2016	184
9	Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors Cancer Immunology Research ·Enxiu Wang,Liang-Chuan Wang,Ching‐Yi Tsai,Vijay Bhoj,Evan W. Roberts,Edmund K. Moon,Kheng Newick,Jing Sun,Albert Lo,Timothy Baradet,Michael D. Feldman,David M. Barrett,Ellen Puré,Steven Albelda,Michael C. Milone	2015	91
10	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer Clinical Cancer Research ·Edmund K. Moon,Raghuveer Ranganathan,Evgeniy Eruslanov,Soyeon Kim,Kheng Newick,Shaun O’Brien,Albert Lo,Xiaojun Liu,Yangbing Zhao,Steven Μ. Albelda	2015	96
11	Transbronchial Cryobiopsies: Evidence Moving at Glacial Speed? CHEST Journal ·J.L. Bessich,Laura Frye,Edmund K. Moon,Anthony R. Lanfranco,Andrew R. Haas,Anil Vachani,Daniel H. Sterman	2015	1
12	Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma Immunology Letters ·Gregory T. Kennedy,Brendan F. Judy,Pratik Bhojnagarwala,Edmund K. Moon,Zvi G. Fridlender,Steven Μ. Albelda,Sunil Singhal	2015	3
13	Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors Clinical Cancer Research ·Edmund K. Moon,Liang-Chuan Wang,Douglas V. Dolfi,Caleph B. Wilson,Raghuveer Ranganathan,Jing Sun,Veena Kapoor,John Scholler,Ellen Puré,Michael C. Milone,Carl H. June,James L. Riley,E. John Wherry,Steven Μ. Albelda	2014	344
14	Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases Cancer Research ·Matthew J. Riese,Liang‐Chuan S. Wang,Edmund K. Moon,Rohan P. Joshi,Anjana Ranganathan,Carl H. June,Gary A. Koretzky,Steven Μ. Albelda	2013	106
15	Overcoming intrinsic inhibitory pathways to augment the antineoplastic activity of adoptively transferred T cells: Re-tuning your CAR before hitting a rocky road OncoImmunology ·Liang-Chuan Wang,Matthew J. Riese,Edmund K. Moon,Steven Μ. Albelda	2013	6
16	Adjuvant immunotherapy for non-small cell lung cancer Cancer Treatment Reviews ·Andreia Medeiros,Benjamin Laguna,Edmund K. Moon,Sunil Singhal	2012	36
17	Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptorbreakdown → Clinical Cancer Research ·Edmund K. Moon,Carmine Carpenito,Jing Sun,Liang‐Chuan S. Wang,Veena Kapoor,Jarrod D. Predina,Daniel J. Powell,James L. Riley,Carl H. June,Steven Μ. Albelda	2011	447
18	Gene Therapy for Lung Neoplasms Clinics in Chest Medicine ·Anil Vachani,Edmund K. Moon,Elliot Wakeam,Andrew R. Haas,Daniel H. Sterman,Steven Μ. Albelda	2011	20
19	Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research ·Yangbing Zhao,Edmund K. Moon,Carmine Carpenito,Chrystal M. Paulos,Xiaojun Liu,Andrea Brennan,Anne Chew,Richard G. Carroll,John Scholler,Bruce L. Levine,Steven Μ. Albelda,Carl H. June	2010	366
20	Pharmacologic Activation of the Innate Immune System to Prevent Respiratory Viral Infections American Journal of Respiratory Cell and Molecular Biology ·Guanjun Cheng,Jorma Mänty,Zvi G. Fridlender,Guang‐Shing Cheng,Bei Chen,Nilam S. Mangalmurti,Vassiliki Saloura,ZaiFang Yu,Veena Kapoor,Krystyna Mozdzanowska,Edmund K. Moon,Jing Sun,James L. Kreindler,Noam A. Cohen,Andrew J. Caton,Jan Erikson,Steven Μ. Albelda	2010	20

About Edmund K. Moon

Edmund K. Moon is a scholar working on Immunology, Oncology and Biotechnology, having authored 43 papers that have together received 4.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (13 papers), Virus-based gene therapy research (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Research and Treatments (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Oncology (4.0k citations), Immunology (2.0k citations) and Genetics (1.2k citations). Edmund K. Moon has collaborated with scholars based in United States, Slovakia and Belgium. Frequent co-authors include Steven Μ. Albelda, Marina C. Martinez, Kheng Newick, Shaun O’Brien, Carl H. June, Veena Kapoor, Albert Lo, Liang‐Chuan S. Wang, Jing Sun and Yangbing Zhao. Their work appears in journals such as OncoImmunology, Molecular Therapy, Cancer Research, Clinical Cancer Research and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact